title: Fatal dysrhythmia following initiation of lansoprazole during a long-term course of voriconazole.
authors.affiliation: Department of Hematology, Teikyo University Chiba Medical Center, 3426-3, Anezaki, Ichihara City, Chiba 299-0111, Japan. tsubokura-tky@umin.ac.jp
authors.forename: Masaharu
authors.initials: M
authors.lastname: Tsubokura
authors.forename: Yuji
authors.initials: Y
authors.lastname: Miura
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Itokawa
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Murata
authors.forename: Naoko
authors.initials: N
authors.lastname: Takei
authors.forename: Tadanao
authors.initials: T
authors.lastname: Higaki
authors.forename: Naoko
authors.initials: N
authors.lastname: Murashige
authors.forename: Masahiro
authors.initials: M
authors.lastname: Kami
authors.forename: Tsunehiko
authors.initials: T
authors.lastname: Komatsu
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D000935:Antifungal Agents / Q000009:adverse effects*; D001228:Aspergillosis / Q000188:drug therapy; D004347:Drug Interactions; D017809:Fatal Outcome; D006801:Humans; D064747:Lansoprazole; D008297:Male; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D017180:Tachycardia, Ventricular / Q000139:chemically induced*; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use; D065819:Voriconazole
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D064747:Lansoprazole; D065819:Voriconazole